These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26054027)

  • 1. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool.
    Corbett MS; Higgins JP; Woolacott NF
    Res Synth Methods; 2014 Mar; 5(1):79-85. PubMed ID: 26054027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Selection Bias on Treatment Effect Size Estimates in Randomized Trials of Oral Health Interventions: A Meta-epidemiological Study.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    J Dent Res; 2018 Jan; 97(1):5-13. PubMed ID: 28813182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEPERROR: Risks of systematic errors in drug and non-drug randomized clinical trials assessing intervention effects in patients with unipolar depression.
    Krogh J; Hjorthøj CR; Jakobsen JC; Lindschou J; Kessing LV; Nordentoft M; Gluud C
    J Affect Disord; 2015 Jul; 179():121-7. PubMed ID: 25863907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allocation concealment in randomised trials: defending against deciphering.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9306):614-8. PubMed ID: 11867132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
    Hofmeijer J; Anema PC; van der Tweel I
    J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of selection bias in randomised trials.
    Kahan BC; Rehal S; Cro S
    Trials; 2015 Sep; 16():405. PubMed ID: 26357929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Shiny Balancer - software and imbalance criteria for optimally balanced treatment allocation in small RCTs and cRCTs.
    Grischott T
    BMC Med Res Methodol; 2018 Oct; 18(1):108. PubMed ID: 30326827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
    Barcot O; Boric M; Poklepovic Pericic T; Cavar M; Dosenovic S; Vuka I; Puljak L
    BMC Med Res Methodol; 2019 Aug; 19(1):170. PubMed ID: 31382898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.
    Bialy L; Vandermeer B; Lacaze-Masmonteil T; Dryden DM; Hartling L
    Evid Based Child Health; 2014 Dec; 9(4):1052-9. PubMed ID: 25504975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of risk of bias in controlled studies].
    Buchberger B; von Elm E; Gartlehner G; Huppertz H; Antes G; Wasem J; Meerpohl JJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1432-8. PubMed ID: 25380968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for treating femoral shaft fractures in children and adolescents.
    Madhuri V; Dutt V; Gahukamble AD; Tharyan P
    Evid Based Child Health; 2014 Dec; 9(4):753-826. PubMed ID: 25504970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline testing in cluster randomised controlled trials: should this be done?
    Bolzern JE; Mitchell A; Torgerson DJ
    BMC Med Res Methodol; 2019 May; 19(1):106. PubMed ID: 31101078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studywise minimization: a treatment allocation method that improves balance among treatment groups and makes allocation unpredictable.
    Perry M; Faes M; Reelick MF; Olde Rikkert MG; Borm GF
    J Clin Epidemiol; 2010 Oct; 63(10):1118-22. PubMed ID: 20304606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bias in randomized trials of pharmacological interventions in children and adults.
    Sinha YK; Craig JC; Sureshkumar P; Hayen A; Brien JA
    J Pediatr; 2014 Aug; 165(2):367-371.e1. PubMed ID: 24814415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of selection bias on the test decision. A simulation study.
    Tamm M; Cramer E; Kennes LN; Heussen N
    Methods Inf Med; 2012; 51(2):138-43. PubMed ID: 22101391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring the comparability of comparison groups: is randomization enough?
    Berger VW; Weinstein S
    Control Clin Trials; 2004 Oct; 25(5):515-24. PubMed ID: 15465620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological bias in cluster randomised trials.
    Hahn S; Puffer S; Torgerson DJ; Watson J
    BMC Med Res Methodol; 2005 Mar; 5():10. PubMed ID: 15743523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.